BioLife Sciences Inc.

BLFEOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$156683

P/E Ratio—

52W High$0.0001

52W Low$0.0001

Avg Volume7

Open$0.00

Beta-2290.12

Net Income Financials Revenue

BioLife Sciences Inc. (BLFE) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BLFE · net income · updated Jun 9, 2026

Core profitability metrics

BLFE · net income · margin · TTM · CAGR

Net income was −$1.3M for FY2020 (fiscal year ending 2020-11-30), down 111716.6% year-over-year. Net profit margin was -308.0%. Based on available data, BioLife Sciences Inc. has been profitable since at least 2010.

FY2020 Net Income−$1.3M▼ -111716.6% YoY

Trailing 12M (TTM)−$348,491.047trailing 4 quarters sum

Net Profit Margin-308.0%−$1.3M ÷ $411,695

YoY Change-111716.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2010

▸ FMP /income-statement · Annual · BLFE net income history · BLFE profit margin

Annual net income data

BLFE · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2020Loss−$1.3M▼ 111716.6%-308.0%$411,695

FY2019Loss−$1,134▲ +97.8%—$0

FY2018Loss−$52,715▲ +84.5%—$0

FY2017Loss−$340,000▼ 1673.1%—$0

FY2016Loss−$19,175▲ +33.6%—$0

Net income vs peers (Healthcare)

BLFE vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

BioLife Sciences Inc.YOU

BLFE

−$1.3M-111716.6%-308.0%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

BioLife Sciences Inc. (BLFE) reported net income of −$1.3M for FY2020 (fiscal year ending 2020-11-30), down 111716.6% year-over-year. The net profit margin was -308.0% — meaning the company kept $-3.08 of every dollar of revenue as profit.

Based on available data, BioLife Sciences Inc. has been profitable since at least 2010. Net income reached a peak of $1.7M in FY2010. Data available for 15 fiscal years.

BioLife Sciences Inc.'s net profit margin was -308.0% for FY2020, based on the latest annual results.

Investors sometimes search for "BioLife Sciences Inc. net worth" — the company's market capitalization is a separate figure from BLFE net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BLFE net income · 4 questions

BioLife Sciences Inc. is not currently profitable on an annual basis. The company reported a net loss of $1.3M for FY2020.

is BLFE profitabledoes BLFE make a profitBLFE profitabilityBLFE profitable company

▸ Source: FMP /income-statement · GAAP · BioLife Sciences Inc. · BioLife Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026